Found: 18
Select item for more details and to access through your institution.
Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.
- Published in:
- Journal of Patient-Reported Outcomes, 2024, v. 8, p. 1, doi. 10.1186/s41687-024-00683-2
- By:
- Publication type:
- Article
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1538, doi. 10.1002/onco.13836
- By:
- Publication type:
- Article
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Optimizing the Dosing Regimen of Cetuximab and Ramucirumab Using the Model‐Informed Drug Development Paradigm.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 77, doi. 10.1002/cpt.2919
- By:
- Publication type:
- Article
Evaluating clinical impact of a shortened infusion duration for ramucirumab: a model-based approach.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 635, doi. 10.1007/s00280-020-04223-9
- By:
- Publication type:
- Article
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
- By:
- Publication type:
- Article
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
- By:
- Publication type:
- Article
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 440, doi. 10.1159/000506946
- By:
- Publication type:
- Article
Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087444
- By:
- Publication type:
- Article
Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study.
- Published in:
- Advances in Hematology, 2022, p. 1, doi. 10.1155/2022/8262787
- By:
- Publication type:
- Article
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.
- Published in:
- Liver International, 2021, v. 41, n. 11, p. 2759, doi. 10.1111/liv.14994
- By:
- Publication type:
- Article
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.
- Published in:
- Liver International, 2021, v. 41, n. 3, p. 598, doi. 10.1111/liv.14731
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. i, doi. 10.1111/liv.14277
- By:
- Publication type:
- Article
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2214, doi. 10.1111/liv.14223
- By:
- Publication type:
- Article
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α‐fetoprotein: Outcomes by treatment‐emergent ascites.
- Published in:
- Hepatology Research, 2021, v. 51, n. 6, p. 715, doi. 10.1111/hepr.13638
- By:
- Publication type:
- Article
Regulation of Cisplatin Cytotoxicity by Cu Influx Transporters.
- Published in:
- Metal-Based Drugs, 2010, v. 2010, p. 1, doi. 10.1155/2010/317581
- By:
- Publication type:
- Article
Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.
- Published in:
- Journal of Gastric Cancer, 2023, v. 23, n. 2, p. 289, doi. 10.5230/jgc.2023.23.e15
- By:
- Publication type:
- Article